Delivery Order SPE2DB22D3301-SPE2DB26FX4DN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $16,374.43 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables global pharmaceutical support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,003.41 firm fixed-price delivery order on August 5, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $19,061.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Injectafer 750 mg/15 mL vials. This non-set-aside contract, with a completion date of August 26, 2025, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor vehicle with DLA, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $13,079.20. This competitively awarded, firm fixed-price contract is classified as a child order and represents a non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order has an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $14,143.49 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Injectafer 750 mg/15 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed price delivery order with a ceiling value of $27,463.25 and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation, indicating competitive procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.62 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Injectafer is an intravenous iron replacement therapy used in the treatment of iron...
- The Defense Logistics Agency awarded a $26,818.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Injectafer 750 mg/15 ml vials. The contract, which is a non-set-aside award, has an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $57,793.04 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials. This firm fixed-price, competitively awarded contract was executed on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on April 22, 2025, with a ceiling value of $13,894.13 and an ultimate completion date of April 23, 2025. This competitive award, which carries no set-aside designation, is issued under a firm fixed-price contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4DNDelivery Order
The Defense Logistics Agency awarded a $13,321.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Injectafer 750 mg/15 ml vials on October 31, 2025, with completion targeted for November 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of pharmaceutical products and medical commodities through its DLA Troop Support contract, which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for the iron replacement medication Injectafer exemplifies the company's ongoing role as a key vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 10/31/25 |